Laurema Anniina, Vanamo Kari, Heikkilä Annaleena, Riekkinen Mervi, Heinonen Seppo, Ylä-Herttuala Seppo
A. I. Virtanen Institute, University of Kuopio, Finland.
Am J Obstet Gynecol. 2004 Jan;190(1):264-7. doi: 10.1016/j.ajog.2003.07.010.
In utero gene therapy has a potential to correct genetic disorders before the first clinical symptoms appear. Our aim was to examine whether the exocoelomic cavity between amniotic and chorionic membranes offers a minimally invasive route for gene transfer to the fetus during early pregnancy.
We injected lacZ-adenovirus (4 x 10(9) pfu) during open surgery into the exocoelomic cavity of rat fetuses (n=50) and analyzed the fetuses and rat dams for transgene expression with X-gal staining and polymerase chain reaction.
Giant cells around Reichert's membrane, the outermost extraembryonic membrane in rodents, were transduced; but no transduction was observed in the cells of the fetuses or rat dams.
In rodents, the exocoelomic cavity does not offer a route for gene transfer into the fetus. It was concluded that fetal membranes act as a barrier that prevents adenoviral particles from passing between embryonic cavities.